The chart illustrates the total sales made by a drug company in three different regions between 2002 and 2006. Overall, there was an upward trend in the figure for Asia, while America and Europe witnessed some fluctuations over the period. It is also evident that Asia surpassed America to be the largest sales contributor in 2006.
In 2002, America accounted for the highest share of the total sales, at 41%, while the figure for Europe was 34% and 25% for Asia. Over the first 2 years, the company’s sales in America experienced a remarkable decrease of 14%, before recovering to 30% in the final year.
Meanwhile, the sales proportion of Europe increased slightly from 34% in 2002 to 38% in 2004, followed by a moderate reduction to 30% in 2006.
On the other hand, the company’s sales in Asia grew constantly over the period. Starting at 25% in 2002, the figure then rose notably by 15% over the period, surpassing America to become the largest market in 2006.
